Brooklyn News Review

Whatever happened to the project to crack the wealthy world’s lock on mRNA vaccines?

Gerhardt Boukes, chief scientist at Afrigen Biologics and Vaccines, formulates mRNA for use in a vaccine against COVID-19. The company — based in Cape Town, South Africa — is the linchpin of a global project to enable low- and middle-income countries to make mRNA vaccines against all manner of diseases.

Lower-income countries did not get the COVID vaccines they needed. So the World Bank and other partners tapped a South African company to cook up the (undisclosed) recipe for the Moderna mRNA vaccine.

(Image credit: Tommy Trenchard for NPR)